Verify any claim · lenz.io
Claim analyzed
Science“The eNTRy rules, developed by Richer et al. in 2017, identify specific physicochemical properties—ionizable nitrogen (especially a primary amine), low three dimensionality, and rigidity—that increase the likelihood of compound accumulation in Escherichia coli, thereby improving the potential for antibiotic activity against Gram-negative bacteria.”
The conclusion
The claim accurately captures the core eNTRy rules—ionizable nitrogen, low three-dimensionality, and rigidity—as properties that increase compound accumulation in E. coli and improve Gram-negative antibiotic potential, as established by Richer et al. in 2017. Two minor caveats apply: the original ionizable nitrogen criterion is broader than primary amines alone (secondary amines also qualify), and the foundational paper additionally highlighted amphiphilicity as part of the accumulator profile, which the claim omits. These do not change the practical takeaway but slightly over-narrow the actual rules.
Based on 16 sources: 10 supporting, 0 refuting, 6 neutral.
Caveats
- The eNTRy 'ionizable nitrogen' criterion is broader than primary amines; secondary amines and other ionizable nitrogens can also satisfy the rule, so the claim's 'especially a primary amine' emphasis is somewhat over-specific.
- Richer et al. (2017) also identified amphiphilicity as part of the accumulator profile, which the claim omits entirely.
- These physicochemical properties increase the probability of accumulation but do not guarantee it; efflux mechanisms and other factors mean many amine-containing compounds still fail to accumulate in Gram-negative bacteria.
Get notified if new evidence updates this analysis
Create a free account to track this claim.
Sources
Sources used in the analysis
Here we assess the ability of over 180 diverse compounds to accumulate in Escherichia coli. Computational analysis of the results reveals major differences from the retrospective studies, namely that the small molecules that are most likely to accumulate contain an amine, are amphiphilic and rigid, and have low globularity. These guidelines were then applied to convert deoxynybomycin, a natural product that is active only against Gram-positive organisms, into an antibiotic with activity against a diverse panel of multi-drug-resistant Gram-negative pathogens.
Utilizing a prospective approach examining accumulation in Escherichia coli for over 180 diverse compounds, we found that small molecules have an increased likelihood to accumulate in E. coli when they contain an ionizable Nitrogen, have low Three-dimensionality, and are Rigid. Implementing these guidelines, codified as the 'eNTRy rules' and assisted by the web application www.entry-way.org, we have facilitated compound entry and systematically built Gram-negative activity into Gram-positive-only antibiotics.
Computational analysis of the results reveals major differences from the retrospective studies, namely that the small molecules that are most likely to accumulate contain an amine, are amphiphilic and rigid, and have low globularity. These guidelines were then applied to convert deoxynybomycin, a natural product that is active only against Gram-positive organisms, into an antibiotic with activity against a diverse panel of multi-drug-resistant Gram-negative pathogens. We anticipate that these findings will aid in the discovery and development of antibiotics against Gram-negative bacteria.
Computational analysis of the results reveals major differences from the retrospective studies, namely that the small molecules that are most likely to accumulate contain an amine, are amphiphilic and rigid, and have low globularity. These guidelines were then applied to convert deoxynybomycin, a natural product that is active only against Gram-positive organisms, into an antibiotic with activity against a diverse panel of multi-drug-resistant Gram-negative pathogens. Although globularity was found to best predict accumulators and non-accumulators in combination with flexibility, other measures of three-dimensionality also exhibit the same trend.
Ampicillin and benzylpenicillin are β-lactam antibiotics with identical chemical structures except for a clever synthetic addition of a primary amine group in ampicillin, which promotes its accumulation in Gram-negatives. The results support previous biochemical observations that the primary amine promotes passage through the outer membrane porin OmpF, but also highlight active efflux as a major resistance factor.
A recent study measuring compound accumulation in Gram-negative bacteria, however, has challenged some of these properties, showing that hydrophobic and primary amine-containing compounds could overcome the Gram-negative permeability barrier. Interestingly, these compounds were also rigid, with low globularity.
Molecules that are most likely to accumulate include primary or secondary amines, are rigid, have low globularity, and are amphiphilic. Notably, charge, molecular weight, and clogD7.4 showed no correlative relationship with accumulation. Both these studies successfully used the discovered heuristics to design molecules with improved intracellular accumulation and antibacterial activities.
Recent efforts have generated significant advances in rationalization of compound permeation across Gram-negative cell envelope, leading to emergence of a hierarchy of rules of permeation. Permeation into Gram-negative bacteria differs from that in Gram-positive bacteria because of the two-membrane cell envelope, with active efflux acting across both membranes. Porin-mediated permeation is a multivariate, dynamic process that is governed by multi-step interactions and physicochemical properties of both the antibiotic and the channel.
One feature stood out among the dozen of those compounds that significantly accumulated inside the bacterial cells: They all contained an amine group, a chemical group that contains the element nitrogen. This analysis revealed that a compound should be rigid, rather than flexible, and flat, as opposed to spherical.
The eNTRy rules are empirical guidelines that describe physicochemical features enabling small molecules to enter and accumulate in Gram-negative bacteria.
Here we assess the ability of over 180 diverse compounds to accumulate in Escherichia coli. Computational analysis of the results reveals major differences from the retrospective studies, namely that the small molecules that are most likely to accumulate contain an amine, are amphiphilic and rigid, and have low globularity.
The envelope of Gram-negative bacteria constitutes an impenetrable barrier to numerous classes of antimicrobials. This intrinsic resistance, coupled with acquired multidrug resistance, has drastically limited the treatment options against Gram-negative pathogens. The aim of the present study was to develop and validate an assay for identifying compounds that increase envelope permeability, thereby conferring antimicrobial susceptibility by weakening of the cell envelope barrier in Gram-negative bacteria.
Gram-negative bacteria in particular have significant intrinsic resistance to many classes of antibiotics owing to their outer membrane (OM) which imposes a permeability barrier. Understanding the physicochemical properties that govern permeation through porins is critical for antibiotic development.
Drug uptake in Gram-negative bacteria is an extremely complex biophysical phenomenon because of the different physicochemical pathways and combination of active and passive transport processes involved. However, it is essential to understand the roles of these pathways in a quantitative manner to rationally design drugs that can accumulate in the vicinity of their targets, which will crucially contribute to overcoming the void in Gram-negative drug discovery.
Study shows antibiotic resistance genes persist in E. coli through “genetic capitalism”. Industrial use of antibiotics may cause unusual persistence of resistance genes.
While the eNTRy rules highlight the importance of an ionizable nitrogen, low three-dimensionality, and rigidity for compound accumulation in E. coli, the presence of a primary amine alone is not always sufficient to guarantee accumulation. Studies have shown that a significant number of compounds containing primary amines still do not accumulate, indicating that other factors or specific structural contexts are also critical.
What do you think of the claim?
Your challenge will appear immediately.
Challenge submitted!
Expert review
How each expert evaluated the evidence and arguments
Expert 1 — The Logic Examiner
The claim states that the eNTRy rules identify "ionizable nitrogen (especially a primary amine), low three dimensionality, and rigidity" as increasing likelihood of E. coli accumulation — the qualifier "especially" is probabilistic and hedged, not an absolute assertion that primary amines alone guarantee accumulation. Sources 1–4 confirm the 2017 Richer et al. origin and the triad of amine/rigidity/low globularity; Source 2 explicitly codifies the rule as "ionizable Nitrogen, low Three-dimensionality, and Rigid" (the eNTRy acronym); Source 5 corroborates primary amine importance for outer-membrane passage; Source 7 notes "primary or secondary amines" satisfy the rule, which is consistent with "especially a primary amine" rather than contradicting it. The opponent's argument commits a straw man by treating "especially a primary amine" as "primary amine alone is sufficient," while Source 16's "not sufficient" point is irrelevant to a claim about increased likelihood, not guaranteed accumulation — the proponent's rebuttal correctly identifies this non sequitur. The logical chain from evidence to claim is sound: the evidence directly supports that these three properties increase accumulation likelihood, the "especially primary amine" framing is consistent with the literature, and the claim's probabilistic language ("increase the likelihood") avoids the overstatement the opponent alleges.
Expert 2 — The Context Analyst
The claim accurately summarizes the core eNTRy triad (ionizable nitrogen/amine, low 3D/low globularity, rigidity) derived from Richer et al.'s E. coli accumulation dataset and later codifications, but it omits that the original paper also emphasized amphiphilicity and that the “ionizable nitrogen” is not uniquely a primary amine (secondary amines can also fit) and is not sufficient on its own due to efflux/other determinants (Sources 1-4,7-8). With that context restored, the overall impression—these properties increase the likelihood of E. coli accumulation and can help enable Gram-negative activity—remains correct, though the “especially a primary amine” phrasing is somewhat over-specific relative to the broader “amine/ionizable N” framing in the foundational work (Sources 1-4,7).
Expert 3 — The Source Auditor
High-authority primary literature and NIH-hosted full text (Source 1/4: Richer et al., 2017, and Source 3: PubMed record of the same paper) explicitly report that E. coli accumulators tend to “contain an amine,” are “rigid,” and have “low globularity” (a low-3D proxy), and they demonstrate using these guidelines to engineer Gram-negative activity; high-authority follow-on review text (Source 2, 2021, NIH/PMC) explicitly codifies the eNTRy rules as “ionizable Nitrogen, low Three-dimensionality, and Rigid,” while other credible reviews (e.g., Source 7) describe the amine feature as primary or secondary rather than uniquely primary. Taken together, trustworthy sources strongly support the core triad (ionizable N/amine + low 3D + rigidity increasing likelihood of E. coli accumulation and aiding Gram-negative antibiotic activity), but the claim's parenthetical emphasis “especially a primary amine” is not the way the original rule is stated and is only partially supported (it's broader than primary), making the overall claim mostly true with a caveat about specificity.
Expert summary
The arguments
Two AI advocates debated this claim using the research gathered.
Argument for
Richer et al.'s 2017 prospective accumulation study in Escherichia coli explicitly derived the eNTRy rules, concluding that compounds most likely to accumulate “contain an amine” (i.e., an ionizable nitrogen), are rigid, and have low globularity/three-dimensionality, and then demonstrated these properties can be used to engineer Gram-negative antibacterial activity (e.g., converting deoxynybomycin into a broad-spectrum agent) (Source 1: PMC “Predictive rules for compound accumulation yield a broad-spectrum antibiotic”; Source 3: PubMed). Multiple independent follow-on reviews and mechanistic studies reiterate the same triad—ionizable nitrogen (often a primary amine), low 3D character, and rigidity—as increasing E. coli accumulation and thereby improving Gram-negative antibiotic potential, including explicit mention of primary amines promoting Gram-negative accumulation and outer-membrane passage (Source 2: PMC “Facilitating Compound Entry…”; Source 7: PMC “Permeability barriers…”; Source 5: PubMed “Breaching the Barrier…”).
Your argument conflates the broad eNTRy rule of "an amine" with the claim's specific assertion of a "primary amine" as the key ionizable nitrogen, but Source 7 explicitly states that "primary or secondary amines" both promote accumulation, meaning the claim's privileging of primary amines specifically is an overstatement that your cited sources do not actually support. Furthermore, you conveniently ignore Source 16, which directly states that "the presence of a primary amine alone is not always sufficient to guarantee accumulation" and that many primary amine-containing compounds still fail to accumulate — fatally undermining the claim's assertion that these properties "increase the likelihood" in a way that singles out primary amines as the decisive ionizable nitrogen feature.
Argument against
The claim overstates the precision of the eNTRy rules by asserting that a "primary amine" specifically is the key ionizable nitrogen, when Source 7 explicitly states that "primary or secondary amines" both promote accumulation, and Source 16 directly undermines the claim by noting that "the presence of a primary amine alone is not always sufficient to guarantee accumulation" and that many primary amine-containing compounds still fail to accumulate. Furthermore, the original 2017 research (Sources 1, 3, and 4) describes the key property not narrowly as a "primary amine" but more broadly as containing "an amine" combined with amphiphilicity and low globularity — meaning the claim's characterization of the eNTRy rules as specifically privileging a primary amine as the decisive ionizable nitrogen misrepresents the actual, more nuanced findings of Richer et al.
You're attacking a straw man: the claim says “ionizable nitrogen (especially a primary amine)” alongside low three-dimensionality and rigidity, which is fully consistent with Richer et al.'s finding that top accumulators “contain an amine” and are rigid with low globularity (Sources 1, 3, 4) and with later summaries explicitly codifying the rule as “ionizable Nitrogen” (Source 2) while noting primary or secondary amines can satisfy it (Source 7). And your appeal to Source 16's “not sufficient” point is a non sequitur—nothing in the motion claims a primary amine alone guarantees accumulation; it claims these properties increase likelihood, which the prospective accumulation data and successful Gram-negative activity engineering directly support (Sources 1, 2, 3).